$BBOT
BridgeBio Oncology Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
BBOT chart
What traders are saying about $BBOT
Latest postsBridgeBio Oncology Therapeutics, Inc. news
- BridgeBio Oncology Therapeutics (BBOT) Reports $315M Cash Position, Poised for KRAS-Targeted Advances
GuruFocus ·
- BridgeBio Oncology Therapeutics Q3 2026 Earnings Results and Report
MarketBeat ·
- BridgeBio Oncology Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Form 8K BridgeBio Oncology Therapeutics Inc For: 10 November By Investing.com
Investing.com India ·
- BridgeBio Oncology Therapeutics 3Q 2026: EPS ($0.43) — 10-Q Summary
TradingView ·
- BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Yahoo Finance ·
- Net current asset value per share of BridgeBio Oncology Therapeutics, Inc. – BMV:BBOT
TradingView ·
- BridgeBio Oncology Therapeutics, Inc. (BBOT) Seasonal returns chart
Yahoo Finance UK ·
- BridgeBio Oncology Therapeutics' Yong Ben to Resign as Chief Medical and Development Officer
TradingView ·
- BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- BridgeBio Oncology Therapeutics (BBOT) Bets Big On A Narrower KRAS Playbook
Yahoo Finance ·
- Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharmadive.com ·
BridgeBio Oncology Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$134.0M | -$74.3M | -$41,692 |
| Diluted EPS | $-4.30 | $-5756.41 | – |
| Total assets (year end) | $448.4M | $164.3M | $332,894 |
| Cash and equivalents (year end) | $373.7M | $30.9M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BridgeBio Oncology Therapeutics, Inc.
- Ticker
- BBOT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1869105
- Former names
- Helix Acquisition Corp. II
Frequently asked questions
What exchange is BridgeBio Oncology Therapeutics, Inc. listed on?
BridgeBio Oncology Therapeutics, Inc. trades on the Nasdaq under the ticker symbol BBOT.
What industry is BridgeBio Oncology Therapeutics, Inc. in?
BridgeBio Oncology Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is BridgeBio Oncology Therapeutics, Inc. headquartered?
BridgeBio Oncology Therapeutics, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does BridgeBio Oncology Therapeutics, Inc.'s fiscal year end?
BridgeBio Oncology Therapeutics, Inc.'s fiscal year ends on December 31.